Literature DB >> 22426149

CTCF mediates effect of insulin on glucagon expression.

Shanli Tsui1, Jie Gao, Charles Wang, Luo Lu.   

Abstract

Pancreatic islet α-cell development and glucagon production are mainly regulated by Pax6 in the homeobox gene families. However, the molecular mechanism fine-tuning the regulation of these events in α-cell still remains unclear. In ocular cells, Pax6 transcription is regulated by CTCF through its binding to specific sites in Pax6 promoter. In this study, CTCF-mediated regulations of islet α-cell development and glucagon production were investigated in both CTCF transgenic mice and α-TC-1-6 cells. Over-expression of CTCF in transgenic mice affected development of pancreatic islets by significantly suppressing α-cell population in both embryonic and adult pancreases. The effect of CTCF on Pax6 gene expression and subsequently, on pro-glucagon production was however, examined in pancreatic islet α-cells. Over-expression and knock-down of CTCF directly affected Pax6 expression. More importantly, the CTCF binding sites upstream from Pax6 p0 promoter were required for regulating p0 promoter activity in islet α-cells. Stimulation of α-cells with insulin resulted in a significant increase in CTCF expression and a decrease in Pax6 expression, and consequently suppressed pro-glucagon expression. In contrast, these insulin-induced effects were blocked by knockdown of CTCF mRNA with specific siRNA in α-cells. Altogether, our results demonstrated for the first time that CTCF functions as a switch-like molecule between the insulin signaling and the regulations of Pax6 and glucagon expression in pancreatic islet α-cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426149      PMCID: PMC3875169          DOI: 10.1016/j.yexcr.2012.03.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  57 in total

1.  Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development.

Authors:  M Sander; A Neubüser; J Kalamaras; H C Ee; G R Martin; M S German
Journal:  Genes Dev       Date:  1997-07-01       Impact factor: 11.361

2.  Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways.

Authors:  I B Leibiger; B Leibiger; T Moede; P O Berggren
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

3.  Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF.

Authors:  M Burcin; R Arnold; M Lutz; B Kaiser; D Runge; F Lottspeich; G N Filippova; V V Lobanenkov; R Renkawitz
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene.

Authors:  E M Klenova; R H Nicolas; S U; A F Carne; R E Lee; V V Lobanenkov; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

Review 5.  The beta cell transcription factors and development of the pancreas.

Authors:  M Sander; M S German
Journal:  J Mol Med (Berl)       Date:  1997-05       Impact factor: 4.599

6.  A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.

Authors:  G N Filippova; A Lindblom; L J Meincke; E M Klenova; P E Neiman; S J Collins; N A Doggett; V V Lobanenkov
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

7.  Homologous DNA sequences and cellular factors are implicated in the control of glucagon and insulin gene expression.

Authors:  M Cordier-Bussat; C Morel; J Philippe
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

8.  Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas.

Authors:  L St-Onge; B Sosa-Pineda; K Chowdhury; A Mansouri; P Gruss
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

Review 9.  The tumor suppressor role of CTCF.

Authors:  Francesco Paolo Fiorentino; Antonio Giordano
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

10.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.

Authors:  G N Filippova; S Fagerlie; E M Klenova; C Myers; Y Dehner; G Goodwin; P E Neiman; S J Collins; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more
  5 in total

1.  CCCTC-binding factor mediates effects of glucose on beta cell survival.

Authors:  S Tsui; W Dai; L Lu
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

2.  Dietary intervention preserves β cell function in mice through CTCF-mediated transcriptional reprogramming.

Authors:  Ruo-Ran Wang; Xinyuan Qiu; Ran Pan; Hongxing Fu; Ziyin Zhang; Qintao Wang; Haide Chen; Qing-Qian Wu; Xiaowen Pan; Yanping Zhou; Pengfei Shan; Shusen Wang; Guoji Guo; Min Zheng; Lingyun Zhu; Zhuo-Xian Meng
Journal:  J Exp Med       Date:  2022-06-02       Impact factor: 17.579

Review 3.  Tales from topographic oceans: topologically associated domains and cancer.

Authors:  Moray J Campbell
Journal:  Endocr Relat Cancer       Date:  2019-11       Impact factor: 5.678

4.  A network biology workflow to study transcriptomics data of the diabetic liver.

Authors:  Martina Kutmon; Chris T Evelo; Susan L Coort
Journal:  BMC Genomics       Date:  2014-11-15       Impact factor: 3.969

5.  Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes.

Authors:  Amanda M Ackermann; Zhiping Wang; Jonathan Schug; Ali Naji; Klaus H Kaestner
Journal:  Mol Metab       Date:  2016-01-11       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.